Antoman, Cristin A.
HRN: 24-69-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
METRONIDAZOLE 500MG (TAB)
03/25/2024
03/28/2024
PO
500 Mg
TID
Cystic Mass On The Vaginal Wall
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes